AusCann Group Holdings Limited announced that the appointment of experienced medicinal cannabis and corporate finance executive Mr. Brett Mitchell as an Independent Non-executive Director. Mr. Mitchell is a corporate finance executive with over 25 years of experience in the venture capital and
equity capital markets, on transactions in the natural resources, technology and life sciences sectors. He has been involved in the founding, financing and management of both private and publicly-listed companies, including the first LSE listed medical cannabis company - MGC Pharmaceuticals Ltd. (MXC), Australian lithium developer Delta Lithium Ltd. (DLI) and private medical cannabis company Levin Health Limited. Mr. Mitchell is also a founder and director of Chieftain Securities Pty Ltd, a Perth based specialist Corporate Advisory and ECM firm. He is currently a Non-executive Director of Uvre Limited. Mr. Mitchell holds a Bachelor of Economics from the University of Western Australia. He is also a member of the Australian Institute of Company Directors (AICD). As a result of Mr. Mitchell's appointment, Mr. Chris Mews will step down as an Executive Director of the Company but will remain as the Company's Chief Financial Officer (`CFO').